A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer
Suhaila O. Alhaj‐Suliman, Youssef W. Naguib, Emad I. Wafa, Sanjib Saha, Kareem Ebeid, Xiangbing Meng, Hamada Hashem, Gamal El‐Din A. Abuo‐Rahma, Shujie Yang, Aliasger K. Salem
Topics & Concepts
PaclitaxelEndometrial cancerCancer researchBiologyPopulationCancerIn vivoPharmacologyCombination therapyMedicineGeneticsEnvironmental healthCancer-related Molecular PathwaysCancer therapeutics and mechanismsLung Cancer Research Studies